Secunderabad Healthcare Ltd.
| BSE: 524540 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE930C01016 |
| BSE 00:00 | 04 Mar | Secunderabad Healthcare Ltd |
| NSE 05:30 | 01 Jan | Secunderabad Healthcare Ltd |
| OPEN | 6.17 |
| PREVIOUS CLOSE | 5.99 |
| VOLUME | 309707 |
| 52-Week high | 6.17 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 50 |
| Buy Price | 5.77 |
| Buy Qty | 25.00 |
| Sell Price | 6.10 |
| Sell Qty | 492.00 |
Secunderabad Healthcare Ltd. (SECUNDHEALTH) - News Sector
-
Biocon's drug Itolizumab gets regulator nod to treat Covid-19 patients
5.30 pm | 11 Jul 2020 | Business Standard
The drug which has got approval to treat moderate to severe Covid complications will be manufactured as an intravenous injection at Biocon's Bengaluru...
-
Drug controller approves Biocon's psoriasis drug for emergency Covid-19 use
2.53 pm | 11 Jul 2020 | Press Trust of India
The firm presented the phase II clinical trial results to the drug regulator which were deliberated upon by the Subject Expert Committee of the DCGI's...
-
This pharma stock zooms over 100% in 18 trading days
3.21 pm | 10 Jul 2020 | Business Standard
The stock hit a new high of Rs 723 during the day, up 16 per cent.
-
Natco Pharma's Canadian unit, Celgene sign pact for cancer treatment drug
1.49 pm | 10 Jul 2020 | Press Trust of India
Lenalidomide drug is used to treat various types of cancers by slowing or stopping the growth of aberrant cells
-
Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%
11.07 am | 10 Jul 2020 | Business Standard
At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index
-
Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%
11.07 am | 10 Jul 2020 | Business Standard
At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index
-
Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%
11.07 am | 10 Jul 2020 | Business Standard
At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index
-
Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%
11.07 am | 10 Jul 2020 | Business Standard
At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index
-
Overall fall in volatility giving comfort to the bulls: Nilesh Jain
8.12 am | 10 Jul 2020 | Business Standard
The volatility index, IndiaVIX, fell by 5 per cent and ended at a 4-month low of 24.75 levels on Thursday
-
Granules India surges 7%, hits record high on heavy volumes
2.58 pm | 9 Jul 2020 | Business Standard
The trading volumes on the counter more-than-doubled with a combined 6.6 million shares changing hands on the NSE and BSE till 02:43 pm
-
Jubilant Life: New Covid drug, value unlocking potential to lead to upside
12.49 am | 9 Jul 2020 | Business Standard
Life sciences, pharma segments offer investors value-unlocking opportunities
-
Cipla set to undercut rivals with low-priced generic remdesivir: Report
9.18 pm | 8 Jul 2020 | Reuters
The drug will be available through the government and hospitals only, the company said
-
IOL Chemicals soars 7%, hits new high on rating upgrade by CARE Ratings
2.52 pm | 8 Jul 2020 | Business Standard
The stock has zoomed 302 per cent from its 52-week low of Rs 147 touched on March 25, 2020.
-
Defensive traders should refrain from aggressive bets on Nifty: Nilesh Jain
8.20 am | 7 Jul 2020 | Business Standard
The overall fall in volatility is hinting at no major move in the short-term
-
Mylan gets DGCI nod, to launch generic remdesivir at Rs 4,800 per vial
1.20 am | 7 Jul 2020 | Reuters
Mylan's version comes after two Indian drugmakers, Cipla Ltd and privately-held Hetero Labs Ltd, launched their generic versions of the drug
-
Apollo Hospitals mulls setting up Proton Cancer Centre in Mumbai and Delhi
5.54 pm | 3 Jul 2020 | Business Standard
The company has already set up one such facility at Chennai at an investment of around Rs 1,300 crore, and may be looking at roping investors to fund ...
-
MARKET WRAP: Sensex settles 178 pts higher; defense stocks rally up to 12%
4.19 pm | 3 Jul 2020 | Business Standard
All that happened in the markets today
-
Opto Circuits locked in 5% lower circuit after zooming 1250% in 66 days
11.59 am | 3 Jul 2020 | Business Standard
The stock is trading under Trade to Trade (T2T) segment or 'T' group
-
JB Chemicals gains 4%, nears 52-wk high as PE firm KKR to acquire 54% stake
10.04 am | 3 Jul 2020 | Business Standard
After this transaction, an open offer will be launched to acquire 20.93 million fully paid-up equity shares of JB Chemicals, representing 26 per cent ...
-
Cadila gains 5% on DGCI nod for clinical trials of Covid-19 vaccine
9.46 am | 3 Jul 2020 | Business Standard
The company has completed preclinical development and plans to begin the trials in July 2020
Quick Links for Secunderabad Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
